Experiment 69532
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | SOLLIER,CBD: CAPLAIN,H: DROUET,L:. (2003). NO ALTERATION IN PLATELET FUNCTION OR COAGULATION INDUCED BY EGB761 IN A CONTROLLED STUDY.. 25(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | EVENTS IN PATIENTS RECEIVING GINKGO BILOBA EXTRACT ARE NOT RELATED TO PHARMACOLOGICAL PROPERTIES OF EGB761. DOSES OF GINKGO BILOBA EXTRACT (120,240 AND 480 MG/DAY FOR 14 DAYS) ON HEMOSTASIS, COAGULATION AND FIBRINOLYSIS. THIS STUDY DID NOT REVEAL ANY ALTERATION OF PLATELET FUNCTION OR COAGULATION. THIS SUGGESTS THAT THE REPORTED CLINICAL BLEEDING SOME CASES OF SPONTANEOUS BLEEDING HAVE BEEN REPORTED IN PATIENTS TREATED WITH GINKGO BILOBA. A PROSPECTIVE, DOUBLE-BLIND,RANDOMIZED, PLACEBO-CONTROLLED STUDY WAS CARRIED OUT IN 32 YPUNG MALE HEALTHY VOLUNTEERS TO EVALUATE THE EFFECT OF THREE A COMMERCIAL PRODUCT, EGB-761, WAS USED. |
| Dose amount | 480.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |
| Gender | MALE |